Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 201

Sort by

Sort Order Select

Journal Articles

Outcomes of Melphalan Versus Busulfan with Fludarabine Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Moazzam Shahzad, Abat Khan, Muhammad Kashif Amin, Gohar Rehman, Umar Akram, Kainat Nihar, Muhammad Uzair Ishaq, Areeba Ismail, Muhammad Hamza Sadiq, Sheena Shamoon, Muhammad Shaheer Mannan, Pramod Singh, Abdul Rafae Faisal, Sibgha Gull Chaudhary, Iqra Anwar, Maggie Nelson, Haitham Abdelhakim, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7426.

https://doi.org/10.1182/blood-2024-199400

Published: 2024

Journal Articles

Outcomes after Bone Marrow Versus Peripheral Blood Stem Cells Haploidentical Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis

Moazzam Shahzad, Gohar Rehman, Abat Khan, Muhammad Kashif Amin, Muhammad Uzair Ishaq, Umar Akram, Muhammad Hamza Sadiq, Umar Iqbal Javid Iqbal Choudhary, Sheena Shamoon, Bilal Yasin Khan, Sibgha Gull Chaudhary, Iqra Anwar, Anurag Singh, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7425.

https://doi.org/10.1182/blood-2024-199357

Published: 2024

Journal Articles

Impact of CD34+ Graft Cell Dose on Outcomes after Allogeneic Bone Marrow Transplantation

Sibgha Gull Chaudhary, Moazzam Shahzad, Iqra Anwar, Sohaib Irfan, Muhammad Kashif Amin, Matthew McGuirk, Shaun DeJarnette, Nausheen Ahmed, Al-Ola Abdallah, Sunil Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7424.

https://doi.org/10.1182/blood-2024-198378

Published: 2024

Journal Articles

Busulfan with Cyclophosphamide Versus Busulfan with Fludarabine for Myeloablative Conditioning in Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplant- a Systematic Review and Meta-Analysis

Moazzam Shahzad, Abat Khan, Muhammad Kashif Amin, Pramod Singh, Umar Akram, Kainat Nihar, Muhammad Uzair Ishaq, Areeba Ismail, Salman Sani, Rubab Zahra, Usman Shahbaz, Javeria Shahani, Fatima Akram, Anmolpreet Kaur, Sibgha Gull Chaudhary, Iqra Anwar, Maggie Nelson, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7284.

https://doi.org/10.1182/blood-2024-202593

Published: 2024

Journal Articles

Absolute Lymphocyte Count As a Predictor of Safety and Efficacy Post CART for Multiple Myeloma and B Cell Malignancies

Raeef L Rahman, Jianzheng Wu, Lauren N Scott, William Wesson, Razan Mansour, Aung M. Tun, Marc Hoffmann, Al-Ola Abdallah, Dinesh Pal Mudaranthakam, Joseph P. McGuirk, Nausheen Ahmed, Forat Lutfi

Blood (2024) 144 (Supplement 1): 7099.

https://doi.org/10.1182/blood-2024-205978

Published: 2024

Journal Articles

Efficacy of BCMA T-Cell Engagers (TCE) Vs. Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Following BCMA-Directed Therapies, Relapsed/Refractory Multiple Myeloma: The Chicken or the Egg Dilemma

Blood (2024) 144 (Supplement 1): 7098.

https://doi.org/10.1182/blood-2024-207398

Published: 2024

Journal Articles

Sociodemographic and Patient-Related Determinants of Outcomes after Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia and Myelodysplastic Syndromes

Muhammad Umair Mushtaq, Aleenah Mohsin, Sibgha Gull Chaudhary, Muhammad Kashif Amin, Iqra Anwar, Matthew McGuirk, Syed Nasir Abbas Bukhari, Kayla Pfannenstiell, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad

Blood (2024) 144 (Supplement 1): 7902.

https://doi.org/10.1182/blood-2024-200443

Published: 2024

Journal Articles

Impact of Obesity on Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation

Moazzam Shahzad, Aleenah Mohsin, Aqeeb Ur Rehman, Sohaib Irfan, Muhammad Atif Khan, Muhammad Kashif Amin, Matthew McGuirk, Sibgha Gull Chaudhary, Faiza Humayun Khan, Iqra Anwar, Nausheen Ahmed, Al-Ola Abdallah, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7421.

https://doi.org/10.1182/blood-2024-193485

Published: 2024

Journal Articles

Impact of Graft Cell Dose on Outcomes after Matched Sibling Donor Bone Marrow Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Moazzam Shahzad, Amir Kasaeian, Muhammad Kashif Amin, Muhammad Fareed Khalid, Naghmeh Khavandgar, Hediyeh Alemi, Sibgha Gull Chaudhary, Iqra Anwar, Matthew McGuirk, Sunil Abhyankar, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7277.

https://doi.org/10.1182/blood-2024-199953

Published: 2024

Journal Articles

Socioeconomic Disparities in Allogeneic Hematopoietic Cell Transplant Outcomes

Moazzam Shahzad, Zouina Sarfraz, Ben Ponvilawan, Muhammad Kashif Amin, Ankita Gupta, Matthew McGuirk, Sibgha Gull Chaudhary, Iqra Anwar, Leyla O. Shune, Joseph P. McGuirk, Mehdi Hamadani, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 3556.

https://doi.org/10.1182/blood-2024-194451

Published: 2024

Journal Articles

Sociodemographic and Patient-Related Determinants of Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Sibgha Gull Chaudhary, Moazzam Shahzad, Kayla Pfannenstiell, Muhammad Kashif Amin, Amir Kasaeian, Muhammad Fareed Khalid, Hediyeh Alemi, Naghmeh Khavandgar, Iqra Anwar, Matthew McGuirk, Syed Nasir Abbas Bukhari, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 3524.

https://doi.org/10.1182/blood-2024-202271

Published: 2024

Journal Articles

Randomized Phase II Trial of Dendritic Cell/AML Fusion Cell Vaccination Compared to Standard of Care Therapy in AML CR1

Blood (2024) 144 (Supplement 1): 4256.

https://doi.org/10.1182/blood-2024-200876

Published: 2024

Journal Articles

Oncologists' Perspectives and Practices on Minimal Residual Disease Testing in Multiple Myeloma

Fathima Shehnaz Ayoobkhan, Sara Shatnawi, Moazzam Shahzad, Aqeeb Ur Rehman, Sohaib Irfan, Raabia Qureshi, Arooq Khalid, Sibgha Gull Chaudhary, Faiz Anwer, Briha Ansari, Joseph P. McGuirk, Mohamad Mohty, Nausheen Ahmed, Al-Ola Abdallah, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 5045.

https://doi.org/10.1182/blood-2024-203904

Published: 2024

Journal Articles

The Use of the Montreal Cognitive Assessment to Predict Neurotoxicity Post CD19 and BCMA CART

Hannah Katz, Lauren N Scott, Pilar Thangwaritorn, Jianzheng Wu, William Wesson, Dinesh Pal Mudaranthakam, Shaun DeJarnette, Al-Ola Abdallah, Marc Hoffmann, Forat Lutfi, Sunil Abhyankar, Leyla O. Shune, Muhammad Umair Mushtaq, Anurag Singh, Haitham Abdelhakim, Joseph P. McGuirk, Muhammad Mahdi Nashatizadeh, Liz Muenks, Nausheen Ahmed

Blood (2024) 144 (Supplement 1): 5030.

https://doi.org/10.1182/blood-2024-199312

Published: 2024

Journal Articles

Racial and Ethnic Differences in Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel or Ciltacabtagene Autoleucel

Lauren C. Peres, Alicia Richards, Surbhi Sidana, Laura B. Oswald, Danai Dima, Aimaz Afrough, Leyla O. Shune, Shonali Midha, Omar Castaneda, Christopher Ferreri, James A Davis, Oren Pasvolsky, Christen M. Dillard, Megan M Herr, Mehmet H. Kocoglu, Shebli Atrash, Brandon Blue, Evguenia Ouchveridze, Joseph P. McGuirk, Charlotte B Wagner, Radhika Bansal, Patrick Costello, Kinaya Smith, Alex Lieberman-Cribbin, Gabriel De Avila, Sneha Purvey, Hitomi Hosoya, Lekha Mikkilineni, Gurbakhash Kaur, Mahmoud R. Gaballa, Peter A. Forsberg, Ciara Louise Freeman, Murali Janakiram, Myo Htut, Sireesha Asoori, Nilesh Kalariya, Djordje Atanackovic, Binod Dhakal, Jack Khouri, Shahzad Raza, Ran Reshef, Melissa Alsina, Frederick L. Locke, Omar Nadeem, Faiz Anwer, Larry D Anderson, Jr., Shambavi Richard, Yi Lin, Thomas Martin, Peter M. Voorhees, Krina K. Patel, Doris K. Hansen, Douglas W Sborov

Blood (2024) 144 (Supplement 1): 3785.

https://doi.org/10.1182/blood-2024-210078

Published: 2024

Journal Articles

Predictors and Characterization of Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) in Patients with Multiple Myeloma Receiving Teclistamab

Blood (2024) 144 (Supplement 1): 3337.

https://doi.org/10.1182/blood-2024-206357

Published: 2024

Journal Articles

CAR T Cell Therapy in Early Relapsed/Refractory Large B-Cell Lymphoma: Real World Analysis from the Cell Therapy Consortium

Alexandra E. Rojek, Nausheen Ahmed, Marina Gomez Llobell, Sairah Ahmed, Marie Hu, Monica Mead, Andy Chen, Vivek Patel, Jamie Brower, Veronika Bachanova, Richard T. Maziarz, Olalekan O. Oluwole, Michael R Bishop, David L. Porter, Miguel Angel Perales, Joseph P. McGuirk, Peter A. Riedell, Daniel J. Landsburg

Blood (2024) 144 (Supplement 1): 4503.

https://doi.org/10.1182/blood-2024-198153

Published: 2024

Journal Articles

Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A Comparative Study with the Cartitude-1 Trial

Ishita Kamboj, Darryl Chang, Alma Habib, Andrew Vegel, Emily Struble, Hira Shaikh, Christopher Strouse, James A Davis, Aliya Rashid, Kevin Graf, Kimberly M Green, Muhammad Umair Mushtaq, Zahra Mahmoudjafari, Hamza Hashmi, Joseph P. McGuirk, Al-Ola Abdallah, Shebli Atrash, Abdullah Mohammad Khan, Nausheen Ahmed

Blood (2024) 144 (Supplement 1): 2411.2.

https://doi.org/10.1182/blood-2024-199187

Published: 2024

Journal Articles

Treatment of Relapsed/Refractory Multiple Myeloma with Ciltacabtagene Autoleucel or Idecabtagene Vicleucel in Racial Minorities-a Multicenter Study

Darryl Chang, Alma Habib, Andrew Vegel, Emily Struble, Hira Shaikh, Christopher Strouse, Kimberly M Green, Muhammad Umair Mushtaq, Zahra Mahmoudjafari, Hamza Hashmi, Joseph P. McGuirk, Abdullah Mohammad Khan, Al-Ola Abdallah, Nausheen Ahmed, Shebli Atrash, Manisha Bhutani

Blood (2024) 144 (Supplement 1): 2404.

https://doi.org/10.1182/blood-2024-208692

Published: 2024

Journal Articles

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged over 70 Years with Myelofibrosis

Moazzam Shahzad, Muhammad Kashif Amin, Ben Ponvilawan, Hana Qasim, Matthew McGuirk, Sibgha Gull Chaudhary, Iqra Anwar, Abat Khan, Abdulraheem Yacoub, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 2172.

https://doi.org/10.1182/blood-2024-193357

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Outcomes of Melphalan Versus Busulfan with Fludarabine Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Outcomes after Bone Marrow Versus Peripheral Blood Stem Cells Haploidentical Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis

Impact of CD34+ Graft Cell Dose on Outcomes after Allogeneic Bone Marrow Transplantation

Busulfan with Cyclophosphamide Versus Busulfan with Fludarabine for Myeloablative Conditioning in Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplant- a Systematic Review and Meta-Analysis

Absolute Lymphocyte Count As a Predictor of Safety and Efficacy Post CART for Multiple Myeloma and B Cell Malignancies

Efficacy of BCMA T-Cell Engagers (TCE) Vs. Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Following BCMA-Directed Therapies, Relapsed/Refractory Multiple Myeloma: The Chicken or the Egg Dilemma

Sociodemographic and Patient-Related Determinants of Outcomes after Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia and Myelodysplastic Syndromes

Impact of Obesity on Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation

Impact of Graft Cell Dose on Outcomes after Matched Sibling Donor Bone Marrow Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Socioeconomic Disparities in Allogeneic Hematopoietic Cell Transplant Outcomes

Sociodemographic and Patient-Related Determinants of Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Randomized Phase II Trial of Dendritic Cell/AML Fusion Cell Vaccination Compared to Standard of Care Therapy in AML CR1

Oncologists' Perspectives and Practices on Minimal Residual Disease Testing in Multiple Myeloma

The Use of the Montreal Cognitive Assessment to Predict Neurotoxicity Post CD19 and BCMA CART

Racial and Ethnic Differences in Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel or Ciltacabtagene Autoleucel

Predictors and Characterization of Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) in Patients with Multiple Myeloma Receiving Teclistamab

CAR T Cell Therapy in Early Relapsed/Refractory Large B-Cell Lymphoma: Real World Analysis from the Cell Therapy Consortium

Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A Comparative Study with the Cartitude-1 Trial

Treatment of Relapsed/Refractory Multiple Myeloma with Ciltacabtagene Autoleucel or Idecabtagene Vicleucel in Racial Minorities-a Multicenter Study

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged over 70 Years with Myelofibrosis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only